Dr. Jonathan Schatz, MD
Claim this profileUniversity of Miami
Studies Lymphoma
Studies Relapse
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Jonathan Schatz, MD is currently running
Ruxolitinib + Duvelisib
for Lymphoma
This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people with relapsed or refractory NK-cell or T-cell lymphoma. This study has three parts: dose escalation (Part 1), dose expansion (Part 2), and TFH/T-PLL cohort expansion (Part 3).
Recruiting1 award Phase 1
Ruxolitinib
for Lymphoma
The purpose of this study is to test any good and bad effects of the study drug called ruxolitinib. Ruxolitinib works by blocking a protein called JAK. JAK works along with another protein called STAT and is important for survival of many T or NK-cell lymphomas. By blocking JAK, ruxolitinib may cause T or NK-cell lymphomas to shrink.
Recruiting1 award Phase 2
More about Jonathan Schatz, MD
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jonathan Schatz, MD has experience with
- Ruxolitinib
- Duvelisib
Breakdown of trials Jonathan Schatz, MD has run
Prolymphocytic Leukemia
Large Granular Lymphocyte Leukemia
T-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Schatz, MD specialize in?
Jonathan Schatz, MD focuses on Lymphoma and Relapse. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are undergoing treatment.
Is Jonathan Schatz, MD currently recruiting for clinical trials?
Yes, Jonathan Schatz, MD is currently recruiting for 2 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Schatz, MD has studied deeply?
Yes, Jonathan Schatz, MD has studied treatments such as Ruxolitinib, Duvelisib.
What is the best way to schedule an appointment with Jonathan Schatz, MD?
Apply for one of the trials that Jonathan Schatz, MD is conducting.
What is the office address of Jonathan Schatz, MD?
The office of Jonathan Schatz, MD is located at: University of Miami (Data Collection Only), Miami, Florida 33125 United States. This is the address for their practice at the University of Miami (Data Collection Only).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.